Home・Akciju saraksts・Accuray Inc

Accuray Inc

Slēgts

SektorsVeselības aprūpe

0.27 -12.9

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.28

Max

0.31

Galvenie mērījumi
By Trading Economics
Ienākumi	2M -12M
Pārdošana	2.6M 105M
EPS	-0.07
Peļņas marža	-11.259
Darbinieki	990
EBITDA	2.5M -813K

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+12.9% upside

Dividendes
By Acuity
Nākamie ieņēmumi	2026. g. 12. aug.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-22M 32M
Iepriekšējā atvēršanas cena	13.17
Iepriekšējā slēgšanas cena	0.27

Ziņu noskaņojums

By Acuity

50%

175 / 340 Rangs Healthcare

Accuray Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 4. aug. 20:02 UTC

Accuray Inc shares are higher today amid positive market sentiment and declining crude oil prices. Comments on potential peace talks with Iran also support the move.

2026. g. 3. aug. 19:31 UTC

Accuray Inc shares are lower today, with no specific news identified to explain the decline, despite broader market gains.

2026. g. 31. jūl. 23:16 UTC

Accuray Inc shares are lower in after-market trading, with no specific news identified. Broader market pressures also impacted other tech companies, including Apple Inc.

2026. g. 30. jūl. 23:51 UTC

Accuray Inc shares are lower in after-market hours, with no specific news identified for the decline. Broader market conditions remain mixed amid geopolitical concerns.

2026. g. 29. jūl. 23:02 UTC

News

Accuray Inc. announced a $40 million debt exchange and $15 million equity investment to enhance its financial position, with shares trading higher after market close.

2026. g. 28. jūl. 23:16 UTC

Accuray Inc shares are trading lower in after-market hours, reflecting broader market pressures in the technology sector amid concerns over AI spending and competition.

2026. g. 27. jūl. 19:32 UTC

Accuray Inc's shares are declining today, hitting a low after an early high. Broader market conditions, including falling oil prices, may be influencing sentiment.

2026. g. 24. jūl. 19:11 UTC

Accuray Inc's shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains near its one-month low.

2026. g. 22. jūl. 18:51 UTC

Accuray Inc. shares are trading flat, remaining 7.82% below their 20-day moving average amid a lack of upward momentum.

2026. g. 20. jūl. 19:31 UTC

Accuray Inc shares are lower today, diverging from a recent trend of higher closes. Broader market dynamics may be impacting investor sentiment.

Salīdzinājums

Cenas izmaiņa

Accuray Inc Prognoze

Cenas mērķis

By TipRanks

12.9% augšup

Prognoze 12 mēnešiem

Vidējais 0.35 USD 12.9%

Augstākais 0.35 USD

Zemākais 0.35 USD

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Accuray Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

1 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 1 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Accuray Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

175 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.